JCB logo
Accuri Cytometers
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published 24 December 2001. doi:10.1083/jcb1557iti2
This Article
Right arrow PDF (Full Text)
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dove, A. W.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Dove, A. W.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
© The Rockefeller University Press, 0021-9525/2001/12/1093 $5.00
The Journal of Cell Biology, Volume 155, Number 7, December 24, 2001 1093-1093


In This Issue

Turning back an invasion
Internalization-defective mutants prevent invasion.

The ability of tumor cells to migrate through the body and invade new tissues is a major focus for research that could leadto new cancer therapies. On page 1345, Uekita et al. demonstrate that the membrane-bound matrix metalloproteinase MT1-MMP, which functions in both migration and invasion, must be recycled continuously from the cell surface to sustain both processes. Blocking the recycling process inhibits the invasive phenotype.

Previous work had shown that MT1-MMP localizes at the migration edge, but it remained unclear how the enzyme was regulated. The authors show that specific sequences in the cytoplasmic tail of MT1-MMP bind to a component of clathrin-coated pits, and that mutations in these sequences prevent internalization and cause the enzyme to accumulate on the cell surface. Although the internalization-defective enzyme specifically accumulates at the migration edge, it does not promote migration or invasion in various assay systems, indicating that the protein must turn over to remain active.

The authors hypothesize that inactivation of MT1-MMP on the cell surface by degradation or inhibitors necessitates continuous replacement of the enzyme; as front-line troops wear out, they are replaced by new recruits. By defining the small motif required for this recycling process, the authors have also identified a potential molecular target for drugs that might inhibit tumor cell metastasis. {blacksquare}



Alan W. Dove

alanwdove{at}earthlink.net


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?



This Article
Right arrow PDF (Full Text)
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dove, A. W.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Dove, A. W.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents